《2012版美国动脉瘤性蛛网膜下腔出血治疗指南解读》内容简介

    Purpose—The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage （aSAH）。

    Methods—A formal literature search of MEDLINE （November 1, 2006, through May 1, 2010） was performed. Data were synthesized with the use of evidence tables. Writing group members met by teleconference to discuss data-derived recommendations. The American Heart Association Stroke Council's Levels of Evidence grading algorithm was used to grade each recommendation. The guideline draft was reviewed by 7 expert peer reviewers and by the members of the Stroke Council Leadership and Manusc**t Oversight Committees. It is intended that this guideline be fully updated every 3 years.

    《2012版美国动脉瘤性蛛网膜下腔出血治疗指南解读》内容预览

    自发性蛛网膜下腔出血的主要原因是脑动脉瘤破裂，约占SAH的75%——80%.近年来，随着急救医学进展，越来越多aSAH患者在出血后得以存活。既往两版指南经过多年实践已被广大脑血管病医生接受并采纳。但世界各地针对aSAH的诊治又进行了多项临床试验，为制定新的指导性意见提供更为充分的论据。因此在上一版指南发布后3年即进行再次修订。

    新版指南在针对aSAH的危险因素防控、诊断、药物及手术干预、术中麻醉管理、术后监护及远期随访方面新增加总共31条指导意见。9条是针对既往推荐的修订，另有22条推荐则是归纳近几年最新研究成果后总结而成。这些新的推荐或指导，为aSAH的1临床诊疗提供了新的思路。本文对最新2012版aSAH治疗指南进行解读，解释新指南与以往指南的异同点，以期为患者提供更好诊治。

    点击下载***：《2012版美国动脉瘤性蛛网膜下腔出血治疗指南解读》